IRLAB Therapeutics AB (publ) (IRLAB_A) Q2 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Welcome to Tilden Harre Live. Here presentation. I'm for I'm Kristina Thorfgaard Senior Vice President, R and D, Nicolas Waters OG CFO, Gustav Alberg. From our cash flow. Operating profit, So now we're actually looking at hearing about our maintenance analyst for a drug for a RUPA under warrant. We will then for a portion, debit data report, mainly a market access aspect and also please reward and Tom Europe. Some the commercial hard premium pricing, what saw or the commercial market. Unveiled it good argument, so we can have a partner in this group. Nesta Buildpak. The Horox inlet, that's our partner here and the Kansk Group, the store of ex Regulator from FTR, for at Maesla Flam and Next slide, please. Clinic. We are also set that external laboratory, for example technology access Okay. I don't